Zobrazeno 1 - 10
of 349
pro vyhledávání: '"S Pelkonen"'
Autor:
Katariina Lajunen, Anette M. Määttä, Kristiina Malmström, Satu Kalliola, Hanna Knihtilä, Terhi Savinko, L. Pekka Malmberg, Anna S. Pelkonen, Mika J. Mäkelä
Publikováno v:
Clinical and Translational Allergy, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Background The use of component‐resolved allergy diagnostics has provided a clearer understanding of the species‐specific sensitization and severity of potential allergic reactions. This cross‐sectional study aimed to determine whether
Externí odkaz:
https://doaj.org/article/0fd0afd3709046f3b37b49793e2c6cb6
Autor:
Miia Perälä, Meri Kaustio, Alexander Salava, Eveliina Jakkula, Anna S. Pelkonen, Janna Saarela, Anita Remitz, Mika J. Mäkelä
Publikováno v:
JID Innovations, Vol 3, Iss 4, Pp 100203- (2023)
Early-onset, persistent atopic dermatitis (AD) is proposed as a distinct subgroup that may have specific genotypic features. FLG gene loss-of-function variants are the best known genetic factors contributing to epidermal barrier impairment and eczema
Externí odkaz:
https://doaj.org/article/ec37ca17973a4ca79b1527272d1e6353
Autor:
Janne Burman, Pekka Malmberg, Ville-Pekka Seppä, Tuomas Jartti, Sami Remes, Ove Mickelsson, Anna S. Pelkonen, Mika J. Mäkelä
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/cbed7b84980b4ca7a11b2416b97b4a57
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 1, p adv00368 (2021)
Externí odkaz:
https://doaj.org/article/22bcac93e4f44cc18c256a280bdf5367
Autor:
Ville-Pekka Seppä, Javier Gracia-Tabuenca, Anne Kotaniemi-Syrjänen, Kristiina Malmström, Anton Hult, Anna S. Pelkonen, Mika J. Mäkelä, Jari Viik, L. Pekka Malmberg
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/e0ecaaa819be4e23a2ac495bfb96461b
Publikováno v:
Clinical and Experimental Dermatology.
Background Childhood atopic dermatitis (AD) is often followed by other atopic comorbidities such as asthma. Aim To compare the effectiveness of topical tacrolimus (TAC) and topical corticosteroids (TCSs) and their impact on airway inflammation and br
Autor:
Alexander, Salava, Miia, Perälä, Mona, Juppo, Anna S, Pelkonen, Mika J, Mäkelä, Anita, Remitz
Publikováno v:
European Journal of Dermatology. 31:791-797
Atopic dermatitis (AD) has a severe impact on quality of life (QoL).To analyze the impact of AD on QoL of small children with moderate-to-severe AD in a tertiary health care hospital in Helsinki, Finland.Based on interim analysis of this longitudinal
Autor:
Lilla Tamási, Mária Szilasi, Jörgen Syk, Athanasios Xanthopoulos, Tari Haahtela, Paula Rytilä, Federico Lavorini, Anna S. Pelkonen, Abel Pallarés-Sanmartin, Jerzy Chudek, Gabriella Gálffy
Publikováno v:
Pulmonary Therapy. 7:409-427
Asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. Optimal control of these conditions is a constant challenge for both physicians and patients. Poor inhaler practice is widespread and is a
Autor:
Tiina Kaisa Kauppila, Victoria Hinkkanen, Terhi Savinko, Piia Karisola, Anna Kaarina Kukkonen, Marita Paassilta, Anna S. Pelkonen, Mika J. Mäkelä
Background: Milk oral immunotherapy (OIT) may increase the amount of milk protein that can be ingested without triggering an allergic reaction. It is important to understand why some patients benefit from the treatment while others do not. Objective:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b40982835259cb1b513a06f496f8cfa
https://trepo.tuni.fi/handle/10024/142351
https://trepo.tuni.fi/handle/10024/142351
Autor:
Anne Kotaniemi-Syrjänen, Timo Klemola, Petri Koponen, Outi Jauhola, Henrikka Aito, Kristiina Malmström, L. Pekka Malmberg, Eero Rahiala, Seppo Sarna, Anna S. Pelkonen, Mika J. Mäkelä
Publikováno v:
Pediatrics. 150
BACKGROUND AND OBJECTIVES Options to treat and prevent episodic wheezing in children are scarce. Our objective was to assess the efficacy of intermittent tiotropium bromide treatment in early childhood episodic wheezing. METHODS This 48-week, randomi